Production (Stage)
Journey Medical Corporation
DERM
$7.25
-$0.145-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.84% | -17.28% | -4.25% | -12.42% | 7.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.84% | -10.73% | -57.64% | -13.49% | 6.69% |
| Cost of Revenue | -20.19% | -0.49% | -17.79% | -15.78% | -6.93% |
| Gross Profit | 18.80% | -12.50% | -66.76% | -11.60% | 21.93% |
| SG&A Expenses | 25.52% | 2.23% | 31.96% | -14.93% | -36.65% |
| Depreciation & Amortization | 30.84% | -9.11% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.79% | -34.42% | 1.32% | -17.99% | 6.18% |
| Operating Income | 67.06% | 206.18% | -116.78% | 35.10% | -5.53% |
| Income Before Tax | 60.99% | 178.43% | -114.16% | 59.81% | -3.02% |
| Income Tax Expenses | -- | -51.59% | -- | -- | -- |
| Earnings from Continuing Operations | 60.99% | 170.98% | -114.24% | 59.81% | -3.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.99% | 170.98% | -114.24% | 59.81% | -3.02% |
| EBIT | 67.06% | 206.18% | -116.78% | 35.10% | -5.53% |
| EBITDA | 75.65% | 349.42% | -111.52% | 38.62% | -9.23% |
| EPS Basic | 65.92% | 162.30% | -112.77% | 63.81% | 7.15% |
| Normalized Basic EPS | 65.91% | 168.84% | -118.67% | 42.00% | 7.17% |
| EPS Diluted | 65.92% | 156.68% | -115.00% | 63.81% | 7.15% |
| Normalized Diluted EPS | 65.91% | 168.84% | -121.33% | 42.00% | 7.17% |
| Average Basic Shares Outstanding | 14.44% | 14.00% | 11.52% | 11.05% | 10.95% |
| Average Diluted Shares Outstanding | 14.44% | 14.00% | -2.36% | 11.05% | 10.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |